Since dysregulated mTORC1 and CK2 signalling underpin a number of diseases characterized by aberrant protein synthesis and proliferation including cancer, our findings suggest that eIF2β phosphorylation may also play a prominent role in these pathologies. The gene discussed is EIF2B4; the disease is cancer.